ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
EFSD, JDRF and Lilly Extend Collaboration Supporting Type 1 Diabetes Research
biospace
March 09, 2018The European Foundation for the Study of Diabetes (EFSD),?JDRF?and?Eli Lilly and Company?(NYSE: LLY) have agreed to extend their collaboration for the European Programme in Type 1 Diabetes Research through 2020 -
Next Generation Biologics, Janssen's Tremfya, Eli Lilly's Taltz, and Novartis' Cosentyx, Raising the
biospace
March 09, 2018The past three years have brought with them a flurry of branded biologic approvals in dermatology, including four biologics for psoriasis alone -
Lilly Exploring Strategic Alternatives for Animal Health Biz
biospace
February 02, 2018?Eli Lilly and Company?(NYSE: LLY) today announced financial results for the fourth quarter and full year of 2017. -
Lilly and KeyBioscience collaborate to develop potential type 2 diabetes treatment
pharmaceutical-technology
June 13, 2017US-based Eli Lilly and Company has collaborated with Nordic Bioscience subsidiary KeyBioscience to develop Dual Amylin Calcitonin Receptor Agonists (DACRAs), a potential new class of treatments for patients with metabolic disorders?such as type 2 diabetes
Pharma Sources Insight January 2025
